Study of DCC-2812 in Participants With Advanced Genitourinary Cancers

Clinical trial NCT06966024 · RECRUITING

Trial details

NCT number: NCT06966024
Sponsor: Deciphera Pharmaceuticals, LLC
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Renal Cell Carcinoma Urothelial Carcinoma Castration-resistant Prostate Cancer

Start date: 2025-08-27
Primary completion: 2029-02-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.